27th September 2024
GENinCode 5.4p £9.5m (GENI.L)
A specialist in predictive genetics used in patient risk assessment focusing on cardiovascular disease, (CVD), and Ovarian Cancer. CVD includes stroke, heart failure, hypertension and is the leading cause of death and disability worldwide accounting for 1 in every 4 deaths in the US.
Its Interim to June 2024 reported revenue increasing 46% to £1.39m, helped by the first US commercial sales for its LIPID inCode test for the diagnosis of familial h ....
